Werewolf Therapeutics announced its first quarter 2025 financial results and business updates, highlighting significant progress in its clinical programs. The comp ...

Marvel’s Thunderbolts just hit theaters -- will it revive Disney’s stock or fall flat? Here’s what investors should be ...

15 other analysts also take a favorable view of Tesla’s prospects but with an additional 10 Holds and 11 Sells, the overall consensus is Hold (i.e., Neutral). At $284.23, the average price target ...

Intel (NASDAQ:INTC) has ridden a rollercoaster over the past three years – though unfortunately, it’s spent most of that ride heading downhill. Receive undervalued stocks, resilient to market ...